These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 36032609

  • 1. Treatment-Associated Side Effects in Patients with Steroid-Dependent Nephrotic Syndrome.
    Croitoru A, Balgradean M.
    Maedica (Bucur); 2022 Jun; 17(2):285-290. PubMed ID: 36032609
    [Abstract] [Full Text] [Related]

  • 2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rituximab treatment in pediatric patients with steroid-dependent nephrotic syndrome: A tertiary hospital.
    Guzmán Morais B, Ordóñez Álvarez FÁ, Santos Rodríguez F, Martín Ramos S, Fernández Novo G.
    An Pediatr (Engl Ed); 2022 Feb; 96(2):83-90. PubMed ID: 35144901
    [Abstract] [Full Text] [Related]

  • 6. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT, Webb NJ, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pathological and Evolutive Correlations in Steroid Resistant Nephrotic Syndrome in Children.
    Starcea IM, Bogos RA, Scurtu G, Munteanu M, Russu R, Lupu VV, Lupu A, Trandafir L, Miron IC, Mocanu MA.
    Int J Gen Med; 2022 Jan; 15():4187-4193. PubMed ID: 35469261
    [Abstract] [Full Text] [Related]

  • 10. Treatment Outcomes of Pediatric Nephrotic Syndrome Patients Treated in Ayder Comprehensive Specialized and Mekelle General Hospitals, Ethiopia.
    Welegerima Y, Feyissa M, Nedi T.
    Int J Nephrol Renovasc Dis; 2021 Jan; 14():149-156. PubMed ID: 34079333
    [Abstract] [Full Text] [Related]

  • 11. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Jan; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate Mofetil as a Rescue Therapy in Frequently Relapsing/Steroid-Dependent Nephrotic Syndrome in Children; Ability to Maintain Remission.
    Seyedzadeh A, Tohidi MR, Rafati M, Seyedzadeh MS, Hookari S.
    Iran J Kidney Dis; 2021 Sep; 15(5):364-372. PubMed ID: 34582371
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience.
    Hacıhamdioğlu DÖ, Kalman S, Gök F.
    Turk Pediatri Ars; 2015 Mar; 50(1):37-44. PubMed ID: 26078695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.